Transfection Reagent And Equipment Market Hits USD 1.09Bn By 2022: BY Grand View Research, Inc.
The global transfection reagent & equipment market is
expected to reach USD 1,086.02 million by 2022, according to a new report by
Grand View Research, Inc. This anticipated growth in demand can be attributed
to growing need for protein production, biopharmaceutical development, and
vaccine research and development; all of which rely heavily on cytological
R&D and transfection.
Larger market entities are also involved in efforts to
expand their market presence in the Asia Pacific region and tap the high
potential for growth available. Expected growth of genomic and proteomic
research is also a strong factor which will positively impact the growth in
demand for transfection.
Browse full research report on Transfection Reagent And Equipment Market http://www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market
Further key findings from the study suggest:
- Out of
both the broad segments of products available, transfection equipment
accounted for a larger share of the market in 2014 and owing to their
inherently more expensive nature than reagents are expected to maintain
this dominant position over the forecast period.
- The
market space for transfection has an abundant number of methods to achieve
the aforementioned. However, these vary significantly in usage rates and
implementation complexities. Electroporation and liposomal transfection
combine to account for over 30% of the market owing to high associated
advantages.
- Growing
applications of transfection techniques poise the segments in a strong
position and estimated valuation clocks usage of transfection in gene
expression at over USD 130 million and for protein production at over USD
110 million for the year 2014.
- North
America was observed to be responsible for the largest share of revenue in
2014 which amounted to a little over USD 240 million. The United States
houses the headquarters of operations for a number of market leaders and a
number of established research and development. This provides a strong
platform for development, manufacture & distribution various vaccines,
and biopharmaceuticals which fuels market growth.
- However,
it is Asia Pacific region which is anticipated to witness significant
growth over the forecast period in various segments owing to considerable
growth of cytological research, development of biosimilar drugs and high
potential of growth in these relatively untapped regional segments.
- Asia Pacific
is expected to grow at a significant rate over the forecast period in
terms of increasing production and development of vaccines, drugs, and new
biologics. Supportive government initiatives pertaining to increasing
investments by manufacturers and governments in biopharmaceutical
manufacturing and high untapped market opportunities are the important
factors accounting for the expected growth of market in this region over
the forecast period.
- Promega,
Roche and Thermo Fisher owned Life Technologies accounted for the largest
of revenue in 2014 and are involved in new product development for
expansion of their portfolios over the forecast period. Acquisition of
smaller players is also expected over the forecast period by larger
companies
- Key
market players in the Transfection Reagent & Equipment Market include
BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene
Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories
Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies
(Thermo Fisher), and Promega Corporation.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented Transfection Reagent &
Equipment Market on the basis of product, method, application, and region:
Global Transfection reagents & equipment Product Outlook
(Revenue, USD Million, 2012 - 2022)
- Reagents
- Equipment
Global Transfection reagents & equipment Method
Outlook (Revenue, USD Million, 2012 - 2022)
- Electroporation
- Liposomes
- Particle
Bombardment
- Microinjection
- Adenoviral
vectors
- Direct
microinjection
- Calcium
phosphate
- DEAE-dextran
- Magnetic
beads
- Activated
Dendrimers
- Laserfection
Global Transfection reagents & equipment Application
Outlook (Revenue, USD Million, 2012 - 2022)
- Gene
expression studies
- Protein
production
- Transgenic
delivery
- Cancer
research
- Biomedical
research
Transfection reagents & equipment Regional Outlook
(Revenue, USD Million, 2012 - 2022)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- MEA
- South
Africa=
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-transfection-reagent-equipment-market
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com
Comments
Post a Comment